520 related articles for article (PubMed ID: 25263519)
1. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors.
Luo PH; Zhang XR; Huang L; Yuan L; Zhou XZ; Gao X; Li LS
J Recept Signal Transduct Res; 2017 Oct; 37(5):481-492. PubMed ID: 28758854
[TBL] [Abstract][Full Text] [Related]
3. Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors.
Tomlinson SM; Watowich SJ
Antiviral Res; 2012 Feb; 93(2):245-252. PubMed ID: 22193283
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
Erbel P; Schiering N; D'Arcy A; Renatus M; Kroemer M; Lim SP; Yin Z; Keller TH; Vasudevan SG; Hommel U
Nat Struct Mol Biol; 2006 Apr; 13(4):372-3. PubMed ID: 16532006
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain.
Shannon AE; Chappell KJ; Stoermer MJ; Chow SY; Kok WM; Fairlie DP; Young PR
Protein Expr Purif; 2016 Mar; 119():124-9. PubMed ID: 26647367
[TBL] [Abstract][Full Text] [Related]
6. Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.
Piccirillo E; Merget B; Sotriffer CA; do Amaral AT
J Comput Aided Mol Des; 2016 Mar; 30(3):251-70. PubMed ID: 26923377
[TBL] [Abstract][Full Text] [Related]
7. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
Wichapong K; Pianwanit S; Sippl W; Kokpol S
J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
[TBL] [Abstract][Full Text] [Related]
8. A straightforward experimental approach to expression, purification, refolding, and enzymatic analysis of recombinant dengue virus NS2B(H)-NS3pro protease.
Junaid M; Angsuthanasombat C; Wikberg JE; Ali N; Katzenmeier G
Biochemistry (Mosc); 2013 Aug; 78(8):920-4. PubMed ID: 24228881
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic flexibility of West Nile virus protease in solution characterized using small-angle X-ray scattering.
Garces AP; Watowich SJ
Biochemistry; 2013 Oct; 52(39):6856-65. PubMed ID: 24015950
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of a hydrogen bonding network from West Nile virus protease onto Dengue-2 protease improves catalytic efficiency and sheds light on substrate specificity.
Doan DN; Li KQ; Basavannacharya C; Vasudevan SG; Madhusudhan MS
Protein Eng Des Sel; 2012 Dec; 25(12):843-50. PubMed ID: 22972763
[TBL] [Abstract][Full Text] [Related]
12. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
Zhou H; Singh NJ; Kim KS
Proteins; 2006 Nov; 65(3):692-701. PubMed ID: 16972281
[TBL] [Abstract][Full Text] [Related]
13. Product release is rate-limiting for catalytic processing by the Dengue virus protease.
Shannon AE; Pedroso MM; Chappell KJ; Watterson D; Liebscher S; Kok WM; Fairlie DP; Schenk G; Young PR
Sci Rep; 2016 Nov; 6():37539. PubMed ID: 27897196
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel small molecule inhibitors of dengue viral NS2B-NS3 protease using virtual screening and scaffold hopping.
Deng J; Li N; Liu H; Zuo Z; Liew OW; Xu W; Chen G; Tong X; Tang W; Zhu J; Zuo J; Jiang H; Yang CG; Li J; Zhu W
J Med Chem; 2012 Jul; 55(14):6278-93. PubMed ID: 22742496
[TBL] [Abstract][Full Text] [Related]
15. Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase.
Shiryaev SA; Cheltsov AV; Gawlik K; Ratnikov BI; Strongin AY
Assay Drug Dev Technol; 2011 Feb; 9(1):69-78. PubMed ID: 21050032
[TBL] [Abstract][Full Text] [Related]
16. Binding specificity of polypeptide substrates in NS2B/NS3pro serine protease of dengue virus type 2: A molecular dynamics Study.
Yotmanee P; Rungrotmongkol T; Wichapong K; Choi SB; Wahab HA; Kungwan N; Hannongbua S
J Mol Graph Model; 2015 Jul; 60():24-33. PubMed ID: 26086900
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of NS2B-mediated activation of NS3pro in dengue virus: molecular dynamics simulations and bioassays.
Zuo Z; Liew OW; Chen G; Chong PC; Lee SH; Chen K; Jiang H; Puah CM; Zhu W
J Virol; 2009 Jan; 83(2):1060-70. PubMed ID: 18971276
[TBL] [Abstract][Full Text] [Related]
18. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.
de la Cruz L; Nguyen TH; Ozawa K; Shin J; Graham B; Huber T; Otting G
J Am Chem Soc; 2011 Nov; 133(47):19205-15. PubMed ID: 22007671
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
[TBL] [Abstract][Full Text] [Related]
20. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
